Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of chlorobutanol, a preservative with antimicrobial properties, and saline solution. This combination is primarily used in nebulizer solutions as a bacteriostatic preservative that does not cause bronchoconstriction in asthmatic patients. Chlorobutanol disrupts microbial cell membranes and inhibits voltage-gated sodium channels, which may contribute to its mild analgesic effects. ## Properties and Uses Chlorobutanol is a chemical preservative with antibacterial and antifungal properties that is typically used at a concentration of 0.5% to provide long-term stability to multi-ingredient formulations[1][3]. When combined with saline, it creates a bacteriostatic solution that can be safely used in nebulizer treatments without causing bronchoconstriction[4]. ## Mechanism of Action Chlorobutanol works by disrupting the lipid structure of microbial cell membranes, increasing cell permeability and leading to cell lysis[1]. It also inhibits voltage-gated sodium channels at concentrations lower than those used as preservatives, which may contribute to its mild analgesic effects[8]. ## Clinical Applications The chlorobutanol + saline combination has been specifically studied for use in nebulizer solutions, where it demonstrated effective bacteriostatic properties against a range of bacteria and yeasts for up to 28 days[4]. Importantly, when tested in asthmatic subjects, this combination did not cause bronchoconstriction or changes in FEV1 (forced expiratory volume in 1 second), making it a safe preservative option for respiratory medications[4]. ## Safety Profile Studies have shown that chlorobutanol + saline can be safely used in nebulizer solutions without triggering bronchospasm in asthmatic patients[4]. This makes it a valuable alternative to other preservatives that might cause airway irritation or bronchoconstriction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorobutanol + saline.